Evidence linking glycated albumin to altered glomerular nephrin and VEGF expression, proteinuria, and diabetic nephropathy

Kidney International

Volumn 68, Issue 4, 2005, Pages 1554-1561

  Cohen, Margo P ^a   Chen, Sheldon ^a   Ziyadeh, Fuad N ^a   Shea, Elizabeth ^a   Hud, Elizabeth A ^a   Lautenslager, Gregory T ^a   Shearman, Clyde W ^a  

^a NONE

Author keywords

Diabetic nephropathy; Glycated albumin; Nephrin; VEGF

Indexed keywords

CELL PROTEIN; COLLAGEN TYPE 4; GLYCOSYLATED HEMOGLOBIN; NEPHRIN; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; EXCRETION; GLYCATION; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; URINARY EXCRETION;

ALBUMINURIA; ANIMALS; COLLAGEN TYPE IV; DIABETIC NEPHROPATHIES; FLUORESCENT ANTIBODY TECHNIQUE; KIDNEY GLOMERULUS; MALE; MEMBRANE PROTEINS; MICE; MICE, MUTANT STRAINS; PROTEINURIA; SERUM ALBUMIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 31644437497     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00567.x     Document Type: Article

References (55)

1. KESTILA M, LENKKERI W, MANNEKO M, et al: Positionally cloned gene for a novel glomerular protein - nephrin - is mutated in congenital nephrotic syndrome. Mol Cell 1:575-582, 1998
2. RODEWALD R, KARNOVSKY M: Porous structure of the glomerular slit diaphragm in the rat and mouse. J Cell Biol 60:423-433, 1984
3. HUDSON BG, KALLURI R, GUNWAR S, NOELKEN ME: Structure and organization of type IV collagen of renal glomerular basement membrane. Contrib Nephrol 107:163-167, 1994
4. RUOTSALAINEN V, PATRAKKA J, TISARI P, et al: Role of nephrin in cell junction formation in human nephrogenesis. Am J Pathol 157:1905-1916, 2000
5. HOLZMAN LB, ST. JOHN PL, KOVARI IA, et al: Nephrin localizes to the slit pore of the glomerular epithelial cell. Kidney Int 56:1481-1491, 1999
6. AALTONEN P, LUIMULA P, ASTROM E, et al: Changes in the expression of nephrin gene and protein in experimental diabetic nephropathy. Lab Invest 81:1185-1190, 2001
7. FORBES JM, BONNET F, RUSSO LM, et al: Modulation of nephrin in the diabetic kidney: Association with systemic hypertension and increasing albuminuria. J Hypertens 20:985-992, 2002
8. DOUBLIER S, SALVIDIO G, LUPIA E, et al: Nephrin expression is reduced in human diabetic nephropathy. Diabetes 51:1023-1030, 2003
9. TOYODA M, SUZUKI D, UMEZONO T, et al: Expression of human nephrin mRNA in diabetic nephropathy. Nephrol Dial Transplant 19:380-385, 2004
10. BENIGNI A GAGLIARDINI E, TOMASONI S, et al: Selective impairment of gene expression and assembly of nephrin in human diabetic nephropathy. Kidney Int 65:2193-2200, 2004
11. ELLIS NE, STEEFES MW, CHAVERS B, MAUER M: Observations of glomerular epithelial cell structure in patients with type 1 diabetes mellitus. Kidney Int 32:736-741, 1987
12. BJORN SF, BANGSTAD H-J, HANSSEN KF, et al: Glomerular epithelial foot process and filtration slits in IDDM patients. Diabetologia 38:1192-1204, 1995
13. PAGTALUNAN ME, MILLER PL, JUMPING-EAGLE SD, et al: Podocyte loss and progressive glomerular injury in type 2 diabetes. J Clin Invest 99:342-348, 1997
14. VESTRA DM, MASIERO A, ROITER AM, et al: Is podocyte injury relevant in diabetic nephropathy? Diabetes 52:1031-1035, 2003
15. STEFFES MW, SCHMIDT D, McCRERY R, BASGEN JM: Glomerular cell number in normal subjects and type 1 diabetic patients. Kidney Int 59:2104-2113, 2001
16. LANGHAM RG, KELLEY DJ, Cox AJ, et al: Proteinuria and the expression of the podocyte slit-diaphragm protein, nephrin, in diabetic nephropathy: effects of angiotensin converting enzyme inhibition. Diabetologia 45:1572-1576, 2002
17. COHEN MP, ZIYADEH FN: Amadori glucose adducts modulate mesangial cell growth and collagen gene expression. Kidney Int 45:475-484, 1994
18. ZIYADEH FN, HAN C, COHEN JA, et al: Glycated albumin stimulates fibronectin gene expression in glomerular mesangial cells: Involvement of the TGF-β1 system. Kidney Int 54:631-638, 1998
19. COHEN MP, ZIYADEH FN, LAUTENSLAGER GT, et al: Glycated albumin stimulation of PKC-β activity is linked to increased collagen IV production in mesangial cells. Am J Physiol 276:F684-F690, 1999
20. COHEN MP, SHEA EA, SHEARMAN CW: ERK mediates effects of glycated albumin in mesangial cells. Biochem Biophys Res Comm 283:641-643, 2001
21. CHEN S, COHEN MP, LAUTENSLAGER GT, et al: Glycated albumin stimulates TGF-β1 production and protein kinase C activity in glomerular endothelial cells. Kidney Int 59:673-681, 2001
22. COHEN MP, SHARMA K, JIN K, et al: Prevention of diabetic nephropathy in db/db mice with glycated albumin antagonists: A novel treatment strategy. J Clin Invest 95:2338-2345, 1995
23. COHEN MP, ZIYADEH FN, HONG SW, et al: Inhibiting albumin glycation in vivo ameliorates glomerular overexpression of TGF-β1. Kidney Int 61:2025-2032, 2002
24. SHARMA K, MCCUE P, DUNN SR: Diabetic kidney disease in the db/db mouse. Am J Physiol 294:F1138-F1144, 2003
25. HOYA D, HANEDA M, et al: Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes. FASEB 14:439-447, 2000
26. SUSZTAK K, BOTTINGER E, et al: Molecular profiling of diabetic mouse kidney reveals novel genes linked to glomerular disease. Diabetes 53:784-794, 2004
27. BREYER MD, BOTTINGER E, BROSIUS FC, et al: Mouse models of diabetic nephropathy. J Am Soc Nephrol (in press)
28. JACKLE-MEYER I, SZUKICS B, NEUBAUER E, et al: Extracellular matrix proteins as early markers in diabetic nephropathy. Eur J Clin Chem Clin Biochem 33:211-219, 1995
29. KADO S, AOKI A, WADA S, et al: Urinary type IV collagen as a marker of early diabetic nephropathy. Diab Res Clin Pract 31:103-108, 1996
30. YAGAME M, SUZUKI D, JINKE E, et al: Significance of urinary type IV collagen in patients with diabetic nephropathy using a highly sensitive one-step sandwich enzyme immunoassay. J Lab Clin Med 11:110-116, 1997
31. KOTAJIMA N, KIMURA T, KANADA T, et al: Type IV collagen as an early marker for diabetic nephropathy in non-insulin dependent diabetes mellitus. J Diabetes Complic 14:13-17, 2000
32. COHEN MP, LAUTENSLAGER GT, SHEARMAN CW: Increased collagen IV excretion in diabetes. A marker of compromised filtration function. Diabetes Care 24:914-918, 2001
33. COHEN MP, LAUTENSLAGER GT, SHEARMAN CW: Increased urinary Type IV collagen marks the development of glomerular pathology in diabetic db/db mice. Metabolism 12:1435-1440, 2001
34. IGLESIAS-DE LA CRUZ MC, ZIYADEH FN, ISONO M, et al: Effects of high glucose and TGF-(1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes. Kidney Int 62:901-913, 2002
35. DEVRIESE AS, TILTON RG, ELGER M, et al: Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. J Am Soc Nephrol 12:993-1000, 2001
36. FLYVBERG A, DAGNAES-HANSEN F, DEVRIESE AS, et al: Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody. Diabetes 51:3090-3094, 2022
37. SIMON M, GRONE H J, JOHREN O, et al: Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney. Am J Physiol 268:F240-F250, 1995
38. FOSTER RR, HOLE R, ANDERSON K, et al: Functional evidence that vascular endothelial growth factor may act as an autocrine factor in human podocytes. Am J Physiol 284:F1263-F1273, 2003
39. CHEN S, KASAMA Y, LEE JS, et al: Podocyte-derived vascular endothelial growth factor mediates the stimulation of α3 (IV) collagen production by transforming growth factor β1 in mouse podocytes. Diabetes 53:2939-2949, 2004
40. WANG X, MENE P, HOLTHUFER H: Nephrin mRNA regulation by protein kinase C. J Nephrol 14:98-103, 2001
41. ZIYADEH FN, HOFFMAN BB, HAN DC, et al: Long-term prevention of renal insufficiency, excess matrix gene expression and glomerular mesangial matrix expansion by treatment with monoclonal anti-TGF-β antibody in db/db mice. Proc Natl Acad Sci 97:8015-8020, 2000
42. WARTIOVAARA J, OFVERSTEDT L-G, KHOSHNOODI J, et al: Nephrin strands contribute to a porous slit diaphragm scaffold as revealed by electron tomography. J Clin Invest 114:1475-1483, 2004
43. DOUCET M, LONDONO I, GOMEZ-PASCAL A, BENDAYAN M: Glomerular basement membrane selective permeability in short-term streptozotocin-induced diabetic rats. Int J Exp Diab Res 1:19-30, 2000
44. REEVES WB, ANDREOLI TE: Transforming growth factor-β contributes to progressive diabetic nephropathy. Proc Natl Acad Sci 97:7667-7669, 2000
45. REMUZZI G, BETANI T: Pathophysiology of progressive nephropathies. N Engl J Med 339:1448-1458, 1998
46. LINDSCHAU C, QUASS P, MENNE J, et al: Glucose-induced TGF-β1 and TGF-β1 receptor-1 expression in vascular smooth muscle cells is mediated by protein kinase C-α. Hypertension 42:335-341, 2003
47. MENNE J, PARK J-K, BOEHNE M, et al: Diminished loss of proteoglycans and lack of albuminuria in protein kinase C-α -deficient diabetic mice. Diabetes 53:2101-2109, 2004
48. MUNDEL P, SHANKLAND SJ: Podocyte biology and responses to injury. J Am Soc Nephrol 13:3005-3015, 2002
49. KRIZ W, GRETZ N, LEMLEY DK: Progression of glomerular disease: Is the podocyte the culprit? Kidney Int 54:687-697, 1998
50. KRIZ W: Podocyte is the major culprit accounting for the progression of chronic renal disease. Microsc Res Tech 57:189-195, 2002
51. KRIZ W, KRETZLER M, NAGATA M, et al: A frequent pathway to glomerulosclerosis: deterioration of tuft architecture-podocyte damage-segmental sclerosis. Kidney Blood Press Res 19:245-253, 1996
52. RENNEK HG: How does glomerular epithelial cell injury contribute to progressive glomerular damage? Kidney Int 45:S58-S63, 1994
53. KRIZ W: Progressive renal failure - Inability of podocytes to replicate and the consequences for the development of glomerulosclerosis. Nephrol Dial Transplant 11:1738-1742, 1996
54. SALANT DJ: The structural biology of glomerular capillary epithelial cells in proteinuric disease. Curr Opin Nephrol Hypertens 3:1-6, 1994
55. KRIZ W, HACHENTHAL E, NOBLING L, et al: A role for podocytes to counteract capillary wall distention. Kidney Int 45:369-376, 1994